D. Khayat

3.8k citations

129 papers · 2.9k indexed · h-index 24

Impact in

Oncology top 2%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
- HER2/EGFR in Cancer Research
Immunology top 5%
- Immunotherapy and Immune Responses

Papers in

Oncology 68
- Cancer Treatment and Pharmacology 32
- Colorectal Cancer Treatments and Studies 15
- HER2/EGFR in Cancer Research 14
Cancer Research 20
- Breast Cancer Treatment Studies 12

Co-authors: Jean‐Philippe Spano G. Milano Jean‐Charles Soria Olivier Rixe Roger Mouawad Rémi Fagard Alejandro Martı́n François Goldwasser
Journals: Journal of Clinical Oncology (27 papers)Annals of Oncology (10 papers)European Journal of Cancer (7 papers)Melanoma Research (6 papers)Supportive Care in Cancer (3 papers)
Partner nations: France United States Germany

In The Last Decade

D. Khayat

125 papers receiving 2.8k citations

Peers

Countries citing papers authored by D. Khayat

Since Specialization

Citations

This map shows the geographic impact of D. Khayat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Khayat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Khayat more than expected).

Fields of papers citing papers by D. Khayat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Khayat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Khayat. The network helps show where D. Khayat may publish in the future.

Co-authorship network

The 25 scholars most cited alongside D. Khayat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. Khayat Line = papers co-authored together D. Khayat links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Expression of long non-coding RNA MFI2-AS1 is a strong predictor of recurrence in sporadic localized clear-cell renal cell carcinoma Annals of Oncology ·Ronan Flippot, Roger Mouawad, Caroline Zago, Morgan Rouprêt, Éva Compérat, F S Ndiaye, 孔宏智, Christophe Vaessen, Frédérick Allanic, M. Acierno, Nizar M. Tannir, D. Khayat, Xiaoping Su, Gabriel G. Malouf	2017	1
2	Randomized double blind phase IIb trial in advanced NSCLC patients who did not progress after first line platinum based chemotherapy: Vx-001, a therapeutic cancer vaccine, vs placebo as maintenance therapy Annals of Oncology ·Cesare Gridelli, Tudor–Eliade Ciuleanu, M. Dómine Gómez, A. Szczęsna, Isabel Bover, Manuel Cobo, Michal Hrúz, Santiago Viteri, C. Manegold, D. Khayat, J.-Y. Douillard, K. Kosmatopoulos, Vassilis Georgoulias	2017	3
3	Trastuzumab duration effects within patient prognostic subgroups in the PHARE trial Annals of Oncology ·A. Kramar, Thomas Bachelot, Avis Macdonald, Jean‐Yves Pierga, Pierre Kerbrat, Marc Espié, P. Fumoleau, Iris Pauporté, D. Khayat, Gilles Romieu, Xavier Pivot	2014	18
4	Mécanismes de résistance aux thérapeutiques moléculaires ciblées dans le cancer du sein : constats et perspectives Bulletin du Cancer ·Nicolas Magné, Cyrus Chargari, Rosa Conforti, Robert‐Alain Toillon, Ahmad Faiz Ahmad Nazri, Lionel Védrine, D. Khayat, Jean-Philippe Spano	2010	1
5	Comparison of the efficacy and safety of combinations of metopimazine or ondansetron with methylprednisolone in the prevention of delayed emesis in patients receiving chemotherapy Current Medical Research and Opinion ·Joël S. Bloch, Olivier Rixe, Jean‐Baptiste Méric, Andrew Delgado, D. Khayat	2005	10
6	Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome Annals of Oncology ·Jean‐Philippe Spano, Fabrice André, Luc Morat, Laure Sabatier, Benjamin Besse, Christophe Combadière, Philippe Déterre, Alejandro Martı́n, J Azorin, Dominique Valeyre, D. Khayat, T. Le Chevalier, Jean‐Charles Soria	2004	186
7	Phase I-II Study of Irinotecan in Combination With Mitomycin C in Patients With Advanced Gastrointestinal Cancer American Journal of Clinical Oncology ·克彦小野崎, E Antoine, François Guinet, V. Bassot, D. M. Weiss, Morgan E. Grams, 千春和泉元, D. Castaing, H. Bismuth, D. Khayat	2001	6
8	Is anemia a problem for European cancer patients and treating oncologists? PubMed ·D. Khayat	2000	8
9	Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in advanced melanoma Melanoma Research ·Roger Mouawad, D. Khayat, Claude Soubrane	2000	35
10	A double-blind, randomised, parallel study comparing intravenous dolasetron plus dexamethasone and intravenous dolasetron alone for the management of fractionated cisplatin-related nausea and vomiting Supportive Care in Cancer ·A. A. Fauser, Giorgio Pizzocaro, Katherine Lemons, D. Khayat, P M Wilkinson	2000	19
11	A comparative study of Fas and Fas-ligand expression during melanoma progression British Journal of Dermatology ·Claude Soubrane, Roger Mouawad, E Antoine, O Vérola, 克彦小野崎, D. Khayat	2000	45
12	Is there any relationship between interleukin-6/interleukin-6 receptor modulation and endogenous interleukin-6 release in metastatic malignant melanoma patients treated by biochemotherapy? Melanoma Research ·Roger Mouawad, D. Khayat, Guinevera Nance, Éric-Charles Antoine, 克彦小野崎, Claude Soubrane	1999	16
13	[Irinotecan in combination for colon cancer]. PubMed ·Michel Ducreux, 克彦小野崎, Thierry André, Marc Ychou, Topan Septiadi Mediana, D. Khayat	1998	1
14	European experience with irinotecan plus fluorouracil/folinic acid or mitomycin. PubMed ·D. Khayat, 克彦小野崎, Ivan Hlaváček, David Coeffic, A. Benhammouda, М. Б. Шапочкин, G. Bastian	1998	5
15	Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients. Journal of Clinical Oncology ·田久保正洋, Christian Conradt, Sewa S. Legha, D. Khayat, Carmen Scheibenbogen, N. Thatcher, S.H. Goey, Martin Gore, Thierry Dorval, Barry W. Hancock, Cornelis J.A. Punt, Reinhard Dummer, M. F. Avril, E.‐B. Bröcker, A. Benhammouda, Alexander M.M. Eggermont, Maria Pritsch	1998	160
16	Virtual tracheo-bronchial endoscopy: educational and diagnostic value Surgical and Radiologic Anatomy ·D. Buthiau, Éric-Charles Antoine, J.C. Pietté, I Căpălnăşan, P Baldeyrou, D. Khayat	1996	18
17	European School of Oncology European consensus on the use of granulocyte colony-stimulating factor: the example of breast cancer Cancer Chemotherapy and Pharmacology ·Betülay Kılıç, D. Khayat	1996	3
18	Fotemustine, dacarbazine, vindesine combination chemotherapy in advanced malignant melanoma Melanoma Research ·Olivier Rixe, Christian Borel, D. Paraïso, A. Benhammouda, Thierry Petit, Éric-Charles Antoine, J. P. Bizzari, G Auclerc, C. Soubrane, M Weil, B. Giroux, Pierre Banzet, D. Khayat	1995	10
19	Changes of Soluble CD16 Levels in Serum of HIV-Infected Patients: Correlation with Clinical and Biologic Prognostic Factors The Journal of Infectious Diseases ·D. Khayat, C. Soubrane, J.M. Andrieu, S Visonneau, 田原良雄, J.M. Tourani, Kheïra Beldjord, M Weil, D.K. Kapur, C Jacquillat	1990	39
20	Results of a conservative treatment combining induction (neoadjuvant) and consolidation chemotherapy, hormonotherapy, and external and interstitial irradiation in 98 patients with locally advanced breast cancer (IIIA-IIIB) Cancer ·Реваз Лорткипанидзе, F Baillet, M Weil, G Auclerc, M. Housset, Xiaodi Xu, Moncef Sellami, Amina Jindani, L Thill, Maxwell Taylor, D. Khayat	1988	62

About D. Khayat

D. Khayat is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 129 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (32 papers), Colorectal Cancer Treatments and Studies (15 papers), Angiogenesis and VEGF in Cancer (15 papers), HER2/EGFR in Cancer Research (14 papers), Breast Cancer Treatment Studies (12 papers), Lung Cancer Treatments and Mutations (11 papers), Melanoma and MAPK Pathways (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). The work is most often cited by research in Oncology (1.6k citations), Immunology (609 citations), Cancer Research (363 citations), Pulmonary and Respiratory Medicine (566 citations) and Pathology and Forensic Medicine (271 citations). D. Khayat has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Jean‐Philippe Spano, G. Milano, Jean‐Charles Soria, Olivier Rixe, Roger Mouawad, Rémi Fagard, Alejandro Martı́n, François Goldwasser, Claude Soubrane and Stéphane Éderhy. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Melanoma Research and Supportive Care in Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact